Marc Chamberlain

Professor of Neurology and Neurological Surgery. Chief, Division of Neuro-Oncology, University of Washington School of Medicine, Seattle, WA, USA

Professor of Neurology and Neurological Surgery, Chief, Division of Neuro-Oncology and an affiliated member of the Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA at the University of Washington School of Medicine. He received a BS (biochemistry) and BA (zoology) from the University of California, Berkeley in 1973 and his MD from Columbia University, College of Physicians and Surgeons in 1977. After completing a pediatric residency in 1980 and neurology residency in 1985 at the University of California, Los Angeles, CA, he became and completed a neuro-oncology fellowship at the University of California, San Francisco in 1986. He became the program leader of neuro-oncology at the University of California, San Diego (1986-1997), the University of Southern California, Los Angeles, CA (1997-2003), Moffitt Cancer Center, Tampa, FL (2003-2007) and the University of Washington, Seattle, WA (2007-present).

Dr. Chamberlain serves or has served on a number of advisory boards (Schering-Plough, Genentech/Roche, ENZON, Merck Serono, Lilly/Immclone, Pfizer, Merck,Sigma-Tau, Plexxicon, Mundipharma), speakers bureau’s (Schering-Plough, Genentech, Exilexis, Myriad, ENZON, Mundipharma), editorial boards (Neuro-Oncology, CNS Oncology, Cancer, CNS Drugs, Journal of Neuro-Oncology) and national professional organizations (Society of Neuro-Oncology, American Society of Clinical Oncologists, American Academy of Neurology, Radiation Treatment Oncology Group).

He has published over 300 papers in various peer-reviewed journals including NeurologyCancerJournal of Clinical OncologyLancet OncologyNeurosurgeryJournal of NeurosurgeryNeuro-OncologyJournal of Neuro-OncologyCNS Oncology and Archives of Neurology and developed many of the methods used today in evaluating and managing neoplastic meningitis.